Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Influenza

Free Subscription Articles published in Vaccine Retrieve available abstracts of 282 articles: HTML format

Single Articles

June 2008
1. ELLSTROM P , Latorre-Margalef N, Griekspoor P, Waldenstrom J, et al
   Sampling for low-pathogenic avian influenza A virus in wild Mallard ducks: Oropharyngeal versus cloacal swabbing.
   Vaccine. 2008;.
   PubMed     Related articles   
   
   
   
2. EICHELBERGER M , Golding H, Hess M, Weir J, et al
   FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. FUKUSHIMA W , Hayashi Y, Mizuno Y, Suzuki K, et al
   Selection bias in evaluating of influenza vaccine effectiveness: A lesson from an observational study of elderly nursing home residents.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. HULL HF , Frauendienst RS, Gundersen ML, Monsen SM, et al
   School-based influenza immunization.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. HIROTA Y
   Ecological fallacy and scepticism about influenza vaccine efficacy in Japan: The Maebashi Study.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. OZASA K
   The effect of misclassification on evaluating the effectiveness of influenza vaccines.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. HARA M , Sakamoto T, Tanaka K
   Influenza vaccine effectiveness among elderly persons living in the community during the 2003-2004 season.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. MORI M , Oura A, Ohnishi H, Washio M, et al
   Confounding in evaluating the effectiveness of influenza vaccine.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. FUJIEDA M , Maeda A, Kondo K, Fukushima W, et al
   Influenza vaccine effectiveness and confounding factors among young children.
   Vaccine. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. HIROTA Y , Kaji M
    History of influenza vaccination programs in Japan: Prologue to the symposium.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. HIROTA Y , Fukushima W, Fujieda M, Ohfuji S, et al
    Essential tools for assessing influenza vaccine efficacy in improperly conducted studies: A Japanese perspective.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. WASHIO M , Oura A, Mori M
    Ecological studies on influenza infection and the effect of vaccination: Their advantages and limitations.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. NOLAN TM , Richmond PC, Skeljo MV, Pearce G, et al
    Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. LEVIN MJ , Song LY, Fenton T, Nachman S, et al
    Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. JIMENEZ-GARCIA R , Hernandez-Barrera V, Carrasco-Garrido P, de Andres AL, et al
    Coverage and predictors of influenza vaccination among adults living in a large metropolitan area in Spain: A comparison between the immigrant and indigenous populations.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. FURUMOTO A , Ohkusa Y, Chen M, Kawakami K, et al
    Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    May 2008
17. WANG L , Suarez DL, Pantin-Jackwood M, Mibayashi M, et al
    Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. WANG S , Parker C, Taaffe J, Solorzano A, et al
    Heterologous HA DNA vaccine prime-inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. RADOSEVIC K , Rodriguez A, Mintardjo R, Tax D, et al
    Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: Impact of distinct additional adjuvants.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. DENIS J , Acosta-Ramirez E, Zhao Y, Hamelin ME, et al
    Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. GIRARD M , Palkonyay L, Kieny MP
    Report of the 4th meeting on the "Evaluation of pandemic influenza prototype vaccines in clinical trials" World Health Organization, Geneva, Switzerland, 14-15 February 2008.
    Vaccine. 2008;.
    PubMed     Related articles   
    
    
    
22. SMITH KA , Colvin CJ, Weber PS, Spatz SJ, et al
    High titer growth of human and avian influenza viruses in an immortalized chick embryo cell line without the need for exogenous proteases.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. LEE SE , Eick A, Bloom MS, Brundage JF, et al
    Influenza immunization and subsequent diagnoses of group A streptococcus-illnesses among U.S. Army trainees, 2002-2006.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. MYLIUS SD , Hagenaars TJ, Lugner AK, Wallinga J, et al
    Optimal allocation of pandemic influenza vaccine depends on age, risk and timing.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. RIEDL K , Riedl R, von Gabain A, Nagy E, et al
    The novel adjuvant IC31((R)) strongly improves influenza vaccine-specific cellular and humoral immune responses in young adult and aged mice.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. SIVAPRAKASAM V , Douglas J, Selvaraj S, Macintyre S, et al
    The effectiveness of national influenza vaccination policies for at-risk populations over 5 seasons in a Scottish general practice.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    April 2008
27. LUCE BR , Nichol KL, Belshe RB, Frick KD, et al
    Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. WILLIMAN J , Young S, Buchan G, Slobbe L, et al
    DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. GREGERSEN JP
    A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. GREGERSEN JP
    A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. DU N , Li W, Li Y, Liu S, et al
    Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. QUAN FS , Steinhauer D, Huang C, Ross TM, et al
    A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. SHOJI Y , Chichester JA, Bi H, Musiychuk K, et al
    Plant-expressed HA as a seasonal influenza vaccine candidate.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
34. CHAN SS
    Influenza vaccination for healthcare workers: Is it really as effective as we claim?
    Vaccine. 2008;.
    PubMed     Related articles   
    
    
    
35. NORTON SP , Scheifele DW, Bettinger JA, West RM, et al
    Influenza vaccination in paediatric nurses: Cross-sectional study of coverage, refusal, and factors in acceptance.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
36. ABRAMSON ZH , Levi O
    Influenza vaccination among primary healthcare workers.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
37. ROSAS C , Van de Walle GR, Metzger SM, Hoelzer K, et al
    Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
38. SUGIMURA T , Ito Y, Tananari Y, Ozaki Y, et al
    Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. HAYNEY MS , Moran J, Wiegert NA, Burlingham WJ, et al
    Lung transplant patients' T cell responses to influenza vaccine viruses between seasons.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
40. WILLIAMS TL , Luna L, Guo Z, Cox NJ, et al
    Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry.
    Vaccine. 2008;26:2510-2520.
    PubMed     Related articles    Abstract available
    
    
    
41. GIRARD MP , Osterhaus A, Pervikov Y, Palkonyay L, et al
    Report of the third meeting on "Influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization, Geneva, Switzerland, 3-4 December 2007.
    Vaccine. 2008;.
    PubMed     Related articles   
    
    
    
42. PALACHE AM , Beyer WE, Osterhaus AD
    Influenza vaccine dosages.
    Vaccine. 2008;.
    PubMed     Related articles   
    
    
    
43. DE MARE A , Bungener LB, Regts J, de Vries-Idema J, et al
    The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. MINNE A , Huaux F, Jaworska J, Rha RD, et al
    Safety evaluation of pulmonary influenza vaccination in healthy and "asthmatic" mice.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
45. BUNGENER L , Geeraedts F, Ter Veer W, Medema J, et al
    Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
46. ROMER-OBERDORFER A , Veits J, Helferich D, Mettenleiter TC, et al
    Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
47. TORO H , Tang DC, Suarez DL, Zhang J, et al
    Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
48. ILYINSKII PO , Meriin AB, Gabai VL, Zhirnov OP, et al
    Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
49. HOLMAN DH , Wang D, Raja NU, Luo M, et al
    Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
50. LO CY , Wu Z, Misplon JA, Price GE, et al
    Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: Cold-adapted vaccine versus DNA prime-adenovirus boost strategies.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
51. MALTEZOU HC , Maragos A, Katerelos P, Paisi A, et al
    Influenza vaccination acceptance among health-care workers: A nationwide survey.
    Vaccine. 2008;26:1408-10.
    PubMed     Related articles    Abstract available
    
    
    
52. MIZUKAMI T , Imai JI, Hamaguchi I, Kawamura M, et al
    Application of DNA microarray technology to influenza A/Vietnam/1194/2004 (H5N1) vaccine safety evaluation.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
53. CO MD , Orphin L, Cruz J, Pazoles P, et al
    Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
54. SAKABE S , Sakoda Y, Haraguchi Y, Isoda N, et al
    A vaccine prepared from a non-pathogenic H7N7 virus isolated from natural reservoir conferred protective immunity against the challenge with lethal dose of highly pathogenic avian influenza virus in chickens.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
55. NEWALL AT , Scuffham PA, Kelly H, Harsley S, et al
    The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
56. NEWALL AT , Wood JG, Macintyre CR
    Influenza-related hospitalisation and death in Australians aged 50 years and older.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
57. LU P , Bridges CB, Euler GL, Singleton JA, et al
    Influenza vaccination of recommended adult populations, U.S., 1989-2005.
    Vaccine. 2008;26:1786-1793.
    PubMed     Related articles    Abstract available
    
    
    
58. JADHAO SJ , Achenbach J, Swayne DE, Donis R, et al
    Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
    Vaccine. 2008;26:1742-1750.
    PubMed     Related articles    Abstract available
    
    
    
59. VEITS J , Romer-Oberdorfer A, Helferich D, Durban M, et al
    Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
60. ANSALDI F , Bacilieri S, Durando P, Sticchi L, et al
    Cross-protection by MF59trade mark-adjuvanted influenza vaccine: Neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
61. AL-SUKHNI W , Avarino P, McArthur MA, McGeer A, et al
    Impact of public vaccination programs on adult vaccination rates: Two examples from Ontario, Canada.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
62. VAN DEN DOOL C , Van Strien AM, Akker IL, Bonten MJ, et al
    Attitude of Dutch hospital personnel towards influenza vaccination.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
63. ELIASSON DG , Bakkouri KE, Schon K, Ramne A, et al
    CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
64. RIDDA I , Motbey C, Lam L, Lindley IR, et al
    Factors associated with pneumococcal immunisation among hospitalised elderly persons: a survey of patient's perception, attitude, and knowledge.
    Vaccine. 2008;26:234-40.
    PubMed     Related articles    Abstract available
    
    
    
65. SEO SU , Byun YH, Lee EY, Jung EJ, et al
    Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
66. YASSINE HM , Lee CW, Suarez DL, Saif YM, et al
    Genetic and antigenic relatedness of H3 subtype influenza A viruses isolated from avian and mammalian species.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. KOTWAL GJ
    Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing co
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. SEBASTIAN R , Skowronski DM, Chong M, Dhaliwal J, et al
    Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998-2004.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. HELSON R , Olszewska W, Singh M, Megede JZ, et al
    Polylactide-co-glycolide (PLG) microparticles modify the immune response to DNA vaccination.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
70. ZHAN X , Hurwitz JL, Krishnamurthy S, Takimoto T, et al
    Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B.
    Vaccine. 2007;25:8782-93.
    PubMed     Related articles    Abstract available
    
    
    
71. GABRIEL G , Garn H, Wegmann M, Renz H, et al
    The potential of a protease activation mutant of a highly pathogenic avian influenza virus for a pandemic live vaccine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. WACK A , Baudner BC, Hilbert AK, Manini I, et al
    Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
73. STEEL J , Burmakina SV, Thomas C, Spackman E, et al
    A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
74. ITOH Y , Ozaki H, Tsuchiya H, Okamoto K, et al
    A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
75. MCMAHON AW , Iskander JK, Haber P, Braun MM, et al
    Inactivated influenza vaccine (IIV) in children <2 years of age: Examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. CHEN Z , Aspelund A, Jin H
    Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. VAN DER SANDE MA , van Asten L, Straus SM, Schim van der Loeff MF, et al
    Sudden deaths following influenza vaccination: Can this be expected?
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. HULEATT JW , Nakaar V, Desai P, Huang Y, et al
    Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
79. DE BRUIJN I , Meyer I, Gerez L, Nauta J, et al
    Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
80. SCHMIDT-OTT R , Schwarz T, Haase R, Sander H, et al
    Immunogenicity and reactogenicity of a trivalent influenza split vaccine in previously unvaccinated children aged 6-9 and 10-13 years.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
81. AMORIJ JP , Westra TA, Hinrichs WL, Huckriede A, et al
    Towards an oral influenza vaccine: Comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
82. KOKIA ES , Silverman BG, Green M, Kedem H, et al
    Deaths following influenza vaccination-background mortality or causal connection?
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. AMORIJ JP , Saluja V, Petersen AH, Hinrichs WL, et al
    Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. WU F , Huang JH, Yuan XY, Huang WS, et al
    Characterization of immunity induced by M2e of influenza virus.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. ZENG R , Qi X, Gong W, Mei X, et al
    Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
    Vaccine. 2007;25:7422-8.
    PubMed     Related articles    Abstract available
    
    
    
86. LAU JT , Kim JH, Choi KC, Tsui HY, et al
    Changes in prevalence of influenza vaccination and strength of association of factors predicting influenza vaccination over time-Results of two population-based surveys.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
87. OKAMOTO S , Yoshii H, Akagi T, Akashi M, et al
    Influenza hemagglutinin vaccine with poly(gamma-glutamic acid) nanoparticles enhances the protection against influenza virus infection through both humoral and cell-mediated immunity.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
88. VAN DER GOOT JA , van Boven M, Koch G, de Jong MC, et al
    Variable effect of vaccination against highly pathogenic avian influenza (H7N7) virus on disease and transmission in pheasants and teals.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
89. ELLIOTT MB , Chen T, Terio NB, Chong SY, et al
    Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
    Vaccine. 2007;25:7132-44.
    PubMed     Related articles    Abstract available
    
    
    
90. HUBBY B , Talarico T, Maughan M, Reap EA, et al
    Development and preclinical evaluation of an alphavirus replicon vaccine for influenza.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
91. LEE MS , Chen MC, Liao YC, Hsiung CA, et al
    Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
92. HOLM MV , Blank PR, Szucs TD
    Developments in influenza vaccination coverage in England, Scotland and Wales covering five consecutive seasons from 2001 to 2006.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
93. VINCENT AL , Ma W, Lager KM, Janke BH, et al
    Efficacy of intranasal administration of a truncated NS1 modified live influenza virus vaccine in swine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
94. HIBBERT CL , Piedra PA, McLaurin KK, Vesikari T, et al
    Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
95. JORDAN RE , Hawker JI, Ayres JG, Tunnicliffe W, et al
    A case-control study of elderly patients with acute respiratory illness: Effect of influenza vaccination on admission to hospital in winter 2003-2004.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
96. ARNOUX S , Weinberger C, Gessner BD
    Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
97. SEO SU , Lee KH, Byun YH, Kweon MN, et al
    Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. BENOIT AC , Huang Y, Maneewatchararangsri S, Tapchaisri P, et al
    Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
99. COUCH RB , Winokur P, Brady R, Belshe R, et al
    Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.
    Vaccine. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
100. XIE H , Liu T, Chen H, Huang X, et al
     Evaluating the vaccine potential of an influenza A viral hemagglutinin and matrix double insertion DNA plasmid.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
101. CONCEICAO MM , Tonso A, Freitas CB, Pereira CA, et al
     Viral antigen production in cell cultures on microcarriers Bovine parainfluenza 3 virus and MDBK cells.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
102. PARIDA R , Shaila MS, Mukherjee S, Chandra NR, et al
     Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
103. BARQUERO N , Daly JM, Newton JR
     Risk factors for influenza infection in vaccinated racehorses: Lessons from an outbreak in Newmarket, UK in 2003.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
104. COUPLAND C , Harcourt S, Vinogradova Y, Smith G, et al
     Inequalities in uptake of influenza vaccine by deprivation and risk group: Time trends analysis.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
105. PAILLOT R , Kydd JH, Macrae S, Minke JM, et al
     New assays to measure equine influenza virus-specific Type 1 immunity in horses.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
106. PUIG-BARBERA J , Diez-Domingo J, Varea AB, Chavarri GS, et al
     Effectiveness of MF59trade mark-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     August 2007
107. VAWTER DE , Gervais KG, Garrett JE
     Allocating pandemic influenza vaccines in Minnesota: Recommendations of the Pandemic Influenza Ethics Work Group.
     Vaccine. 2007;25:6522-36.
     PubMed     Related articles    Abstract available
     
     
     
108. WRIGHT PF , Karron RA, Belshe RB, Shi JR, et al
     The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
109. SHI H , Liu XF, Zhang X, Chen S, et al
     Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
110. TERNETTE N , Tippler B, Uberla K, Grunwald T, et al
     Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
111. NOLAN SM , Skiadopoulos MH, Bradley K, Kim OS, et al
     Recombinant human parainfluenza virus type 2 vaccine candidates containing a 3' genomic promoter mutation and L polymerase mutations are attenuated and protective in non-human primates.
     Vaccine. 2007;25:6409-22.
     PubMed     Related articles    Abstract available
     
     
     
112. QUINLIVAN M , Nelly M, Prendergast M, Breathnach C, et al
     Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
113. ROY S , Kobinger GP, Lin J, Figueredo J, et al
     Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
114. ABALLEA S , De Juanes JR, Barbieri M, Martin M, et al
     The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: A model-based analysis for Spain.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
115. CARRAT F , Flahault A
     Influenza vaccine: The challenge of antigenic drift.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     July 2007
116. BOS JM , Rietveld E, Moll HA, Steyerberg EW, et al
     The use of health economics to guide drug development decisions: Determining optimal values for an RSV-vaccine in a model-based scenario-analytic approach.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
117. VILA-CORCOLES A , Rodriguez T, de Diego C, Ochoa O, et al
     Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
118. ZUCCOTTI G , Amendola A, Vigano A, Pariani E, et al
     Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
119. BELSHE RB , Newman FK, Wilkins K, Graham IL, et al
     Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
120. AMORIJ JP , Meulenaar J, Hinrichs WL, Stegmann T, et al
     Rational design of an influenza subunit vaccine powder with sugar glass technology: Preventing conformational changes of haemagglutinin during freezing and freeze-drying.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
121. ASANUMA H , Fujihashi K, Miyakoshi T, Yoshikawa T, et al
     Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
122. SONG SK , Moldoveanu Z, Nguyen HH, Kim EH, et al
     Intranasal immunization with influenza virus and Korean mistletoe lectin C (KML-C) induces heterosubtypic immunity in mice.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     June 2007
123. SHARPE M , Lynch D, Topham S, Major D, et al
     Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
124. SINGH SR , Dennis VA, Carter CL, Pillai SR, et al
     Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
125. HOSHI SL , Kondo M, Honda Y, Okubo I, et al
     Cost-effectiveness analysis of influenza vaccination for people aged 65 and over in Japan.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
126. REDLBERGER M , Aberle SW, Heinz FX, Popow-Kraupp T, et al
     Dynamics of antigenic and genetic changes in the hemagglutinins of influenza A/H3N2 viruses of three consecutive seasons (2002/2003 to 2004/2005) in Austria.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
127. ESPOSITO S , Tremolati E, Bellasio M, Chiarelli G, et al
     Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
128. JAMES CM , Foong YY, Mansfield JP, Fenwick SG, et al
     Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     May 2007
129. OSTERHAUS AD
     Pre- or post-pandemic influenza vaccine?
     Vaccine. 2007;.
     PubMed     Related articles   
     
     
     
130. CYR SL , Jones T, Stoica-Popescu I, Brewer A, et al
     Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
131. ATMAR RL , Keitel WA, Cate TR, Munoz FM, et al
     A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
132. YOUN HJ , Ko SY, Lee KA, Ko HJ, et al
     A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
133. SKULL SA , Andrews RM, Byrnes GB, Kelly HA, et al
     Missed opportunities to vaccinate a cohort of hospitalised elderly with pneumococcal and influenza vaccines.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
134. GILL TK , Taylor AW, Watson M
     Trends in influenza immunisation amongst an elderly Australian community.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     April 2007
135. SKULL SA , Andrews RM, Byrnes GB, Kelly HA, et al
     Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
136. BRIGNONE C , Grygar C, Marcu M, Perrin G, et al
     IMP321 (sLAG-3) safety and T cell response potentiation using an influenza vaccine as a model antigen: A single-blind phase I study.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
137. NAGATA T , Toyota T, Ishigaki H, Ichihashi T, et al
     Peptides coupled to the surface of a kind of liposome protect infection of influenza viruses.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
138. MOLINARI NA , Ortega-Sanchez IR, Messonnier ML, Thompson WW, et al
     The annual impact of seasonal influenza in the US: Measuring disease burden and costs.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
139. ANTONIS AF , van der Most RG, Suezer Y, Stockhofe-Zurwieden N, et al
     Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
140. OTSUKA T , Fujinaka H, Katsuyama K, Iizawa M, et al
     Influenza vaccination for severely multiply handicapped persons/children in the 2005-2006 season.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
141. BERTELSEN MF , Klausen J, Holm E, Grondahl C, et al
     Serological response to vaccination against avian influenza in zoo-birds using an inactivated H5N9 vaccine.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
142. GRAY GC , Trampel DW, Roth JA
     Pandemic influenza planning: Shouldn't swine and poultry workers be included?
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
143. MURRIS-ESPIN M , Maitre M, Bosdure E, Dubus JC, et al
     Influenza vaccination in healthcare workers: A survey of coverage in French cystic fibrosis treatment centres.
     Vaccine. 2007;.
     PubMed     Related articles   
     
     
     March 2007
144. HUGHES K , Zachertowska A, Wan S, Li L, et al
     Yield increases in intact influenza vaccine virus from chicken allantoic fluid through isolation from insoluble allantoic debris.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
145. SKULL SA , Andrews RM, Byrnes GB, Kelly HA, et al
     Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: Benefit due to influenza and pneumococcal vaccination not demonstrated.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
146. HALLORAN ME , Piedra PA, Longini IM Jr, Gaglani MJ, et al
     Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
147. OHBA K , Yoshida S, Zahidunnabi Dewan M, Shimura H, et al
     Mutant influenza A virus nucleoprotein is preferentially localized in the cytoplasm and its immunization in mice shows higher immunogenicity and cross-reactivity.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
148. PUSHKO P , Tumpey TM, Van Hoeven N, Belser JA, et al
     Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
149. BALDO V , Baldovin T, Floreani A, Carraro AM, et al
     MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
150. OSTERHAUS AD , Vanlangendonck C
     Chapter III. The second European Influenza Conference--lessons learnt and actions to take. The urgent need for a European influenza task force.
     Vaccine. 2007;25:2155-60.
     PubMed     Related articles   
     
     
     February 2007
151. STEPHENSON I , Das RG, Wood JM, Katz JM, et al
     Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: An international collaborative study.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
152. PHILIPPA J , Baas C, Beyer W, Bestebroer T, et al
     Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
153. SYLTE MJ , Hubby B, Suarez DL
     Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
154. CAPUA I , Marangon S
     The use of vaccination to combat multiple introductions of Notifiable Avian Influenza viruses of the H5 and H7 subtypes between 2000 and 2006 in Italy.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
155. BRIGHT RA , Carter DM, Daniluk S, Toapanta FR, et al
     Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
156. KATZ MA , Tharmaphornpilas P, Chantra S, Dowell SF, et al
     Who gets hospitalized for influenza pneumonia in Thailand? Implications for vaccine policy.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     January 2007
157. NINOMIYA A , Imai M, Tashiro M, Odagiri T, et al
     Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
158. LADDY DJ , Yan J, Corbitt N, Kobasa D, et al
     Immunogenicity of novel consensus-based DNA vaccines against avian influenza.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
159. NAVAS E , Salleras L, Dominguez A, Ibanez D, et al
     Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
160. MBAWUIKE I , Zang Y, Couch RB
     Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
161. ELLIS JA , Martin BV, Waldner C, Dyer KD, et al
     Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice.
     Vaccine. 2007;25:1085-95.
     PubMed     Related articles    Abstract available
     
     
     
162. CYR SL , Jones T, Stoica-Popescu I, Burt D, et al
     C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
163. WONG JP , Christopher ME, Salazar AM, Dale RM, et al
     Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
164. JOHANSSON BE , Brett IC
     Changing perspective on immunization against influenza.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
165. POLAND GA , Jacobson RM, Targonski PV
     Avian and pandemic influenza: An overview.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
166. TARGONSKI PV , Jacobson RM, Poland GA
     Immunosenescence: Role and measurement in influenza vaccine response among the elderly.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
167. JIMENEZ-GARCIA R , Carrasco-Garrido P, Hernandez-Barrera V, de Andres AL, et al
     Estimates of influenza vaccination target population sizes in Spain for the 2006-2007 season.
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
168. MCNEIL SA , Noya F, Dionne M, Predy G, et al
     Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in ad
     Vaccine. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
169. DE JUANES JR , Garcia de Codes A, Arrazola MP, Jaen F, et al
     Influenza vaccination coverage among hospital personnel over three consecutive vaccination campaigns (2001-2002 to 2003-2004).
     Vaccine. 2007;25:201-4.
     PubMed     Related articles    Abstract available
     
     
     December 2006
170. WANG M , Lamberth K, Harndahl M, Roder G, et al
     CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     November 2006
171. ZIMMERMAN RK
     Rationing of influenza vaccine during a pandemic: Ethical analyses.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
172. MONTOMOLI E , Manini I
     Pre-emptive vaccination against pandemic influenza virus.
     Vaccine. 2006;.
     PubMed     Related articles   
     
     
     
173. 
     Influenza as an issue on the agenda of different stakeholders. A multidisciplinary point of view.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
174. 
     Influenza as an issue on the agenda of policy makers and government representatives. What can we do? What do we need?
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
175. 
     Influenza as an issue on the agenda of health care workers: what can we do? What do we need?
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
176. 
     Diagnosis and treatment of influenza in primary healthcare: "You can't manage what you can't measure".
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
177. 
     Recommendations and guidelines on influenza vaccination and treatment. A key success factor.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
178. 
     Misconceptions concerning influenza: an overview and clear answers.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
179. 
     Economic and social impact of epidemic and pandemic influenza.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
180. 
     Influenza surveillance: Why?
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
181. 
     Epidemic and pandemic influenza, who cares and how?
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
182. 
     Pandemic preparedness: different perspectives. How ready are we for the next pandemic?
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
183. 
     How to develop and implement pandemic preparedness plans? The need for a coherent European policy.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
184. 
     Proceedings of the 2nd European Influenza Conference, Malta, 11-14 September 2005.
     Vaccine. 2006;24.
     PubMed     Related articles   
     
     
     
185. HUNGNES O
     Early detection of A/California/7/2004-like A(H3N2) strains in Norway during the 2004-2005 season, and emergence of a novel H3N2 genetic sub-variant toward the end.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
186. BREWSTER M , Smith JR, Dutkowski R, Robson R, et al
     Active metabolite from Tamiflu solution is bioequivalent to that from capsule delivery in healthy volunteers: a cross-over, randomised, open-label study.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
187. CHOWELL G , Ammon CE, Hengartner NW, Hyman JM, et al
     Estimation of the reproductive number of the Spanish flu epidemic in Geneva, Switzerland.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
188. ALEXANDER DJ
     An overview of the epidemiology of avian influenza.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
189. CAPUA I , Marangon S
     Control and prevention of avian influenza in an evolving scenario.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
190. PATEL JA , Nguyen DT, Revai K, Chonmaitree T, et al
     Role of respiratory syncytial virus in acute otitis media: Implications for vaccine development.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
191. JAMES CM , Abdad MY, Mansfield JP, Jacobsen HK, et al
     Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     October 2006
192. WANG CS , Wang ST, Lai CT, Lin LJ, et al
     Impact of influenza vaccination on major cause-specific mortality.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
193. KWONG JC , Manuel DG
     Using OHIP physician billing claims to ascertain individual influenza vaccination status.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
194. CHOU CH , Liou WP, Hu KI, Loh CH, et al
     Bell's palsy associated with influenza vaccination: Two case reports.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
195. MUTWIRI G , Benjamin P, Soita H, Townsend H, et al
     Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
196. SKOWRONSKI DM , Masaro C, Kwindt TL, Mak A, et al
     Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
197. KWONG JC , Stukel TA, McGeer AJ, Manuel DG, et al
     Appropriate measures of influenza immunization program effectiveness.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
198. BLAY A , Bessler H, Lahad A, Waitman DA, et al
     Does pneumococcal vaccine reduce influenza morbidity in humans?
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
199. RAMET J , Weil-Olivier C, Sedlak W
     Influenza vaccination: The paediatric perspective.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     September 2006
200. KIENY MP , Costa A, Hombach J, Carrasco P, et al
     A global pandemic influenza vaccine action plan.
     Vaccine. 2006;24.
     PubMed     Related articles    Abstract available
     
     
     
201. TORO H , Tang DC, Suarez DL, Sylte MJ, et al
     Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
202. MULLOOLY JP , Bridges CB, Thompson WW, Chen J, et al
     Influenza- and RSV-associated hospitalizations among adults.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
203. OPITZ L , Salaklang J, Buttner H, Reichl U, et al
     Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
204. KREIJTZ JH , Bodewes R, van Amerongen G, Kuiken T, et al
     Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
205. AUEWARAKUL P , Kositanont U, Sornsathapornkul P, Tothong P, et al
     Antibody responses after dose-sparing intradermal influenza vaccination.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     August 2006
206. PRINCIPI N , Esposito S
     Influenza vaccination in healthy children.
     Vaccine. 2006;.
     PubMed     Related articles   
     
     
     
207. QUAN FS , Compans RW, Cho YK, Kang SM, et al
     Ginseng and Salviae herbs play a role as immune activators and modulate immune responses during influenza virus infection.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
208. GREER CE , Zhou F, Legg HS, Tang Z, et al
     A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
209. AMIDI M , Romeijn SG, Verhoef JC, Junginger HE, et al
     N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: Biological properties and immunogenicity in a mouse model.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
210. RYAN J , Zoellner Y, Gradl B, Palache B, et al
     Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
211. HERRERA GA , Iwane MK, Cortese M, Brown C, et al
     Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     July 2006
212. THOMAS DR , Mason BW, Beer L, Scourfield S, et al
     Surveillance of influenza immunisation uptake in people aged under 65 years with chronic disease.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
213. RIZZO C , Viboud C, Montomoli E, Simonsen L, et al
     Influenza-related mortality in the Italian elderly: No decline associated with increasing vaccination coverage.
     Vaccine. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
214. MCBEAN AM , Jung K, Hebert PL
     Decreasing invasive pneumococcal disease in the elderly: a state-level analysis.
     Vaccine. 2006;24.
     PubMed